Showing results (201-210 of 301) with videos related to

Sort By:
Pageof 31
Cancer Biotherapy & Radiopharmaceuticals|September 25, 2003
Biodistribution of 131I-, 186Re-, 177Lu-, and 88Y-labeled hLL2 (Epratuzumab) in nude mice with CD22-positive lymphomaErnst J Postema, Cathelijne Frielink, Wim J G Oyen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 25, 2015
Enhanced Delivery of SN-38 to Human Tumor Xenografts with an Anti-Trop-2-SN-38 Antibody Conjugate (Sacituzumab Govitecan)Robert M Sharkey, William J McBride, Thomas M Cardillo, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|October 20, 2011
Optimized labeling of NOTA-conjugated octreotide with F-18Peter Laverman, Christopher A D'Souza, Annemarie Eek, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|March 8, 2012
Pretargeted radioimmunotherapy (pRAIT) in medullary thyroid cancer (MTC)Françoise Kraeber-Bodéré, Pierre-Yves Salaun, Catherine Ansquer, et al.
Leukemia & Lymphoma|September 22, 2015
Subcutaneous injections of low doses of humanized anti-CD20 veltuzumab: a phase I study in chronic lymphocytic leukemiaMatt E Kalaycio, O George Negrea, Steven L Allen, et al.
Clinical Colorectal Cancer|November 28, 2002
Phase I radioimmunotherapy trial with iodine-131--labeled humanized MN-14 anti-carcinoembryonic antigen monoclonal antibody in patients with metastatic gastrointestinal and colorectal cancerGeorge Hajjar, Robert M Sharkey, Jack Burton, et al.
Theranostics|January 3, 2017
Preventing Radiobleaching of Cyanine Fluorophores Enhances Stability of Nuclear/NIRF Multimodality Imaging AgentsReinier Hernandez, Sandra Heskamp, Mark Rijpkema, et al.
Blood|October 23, 2008
Properties and structure-function relationships of veltuzumab (hA20), a humanized anti-CD20 monoclonal antibodyDavid M Goldenberg, Edmund A Rossi, Rhona Stein, et al.
Bioconjugate Chemistry|April 28, 2015
Sacituzumab Govitecan (IMMU-132), an Anti-Trop-2/SN-38 Antibody-Drug Conjugate: Characterization and Efficacy in Pancreatic, Gastric, and Other CancersThomas M Cardillo, Serengulam V Govindan, Robert M Sharkey, et al.
Transplantation|April 20, 2002
Anti-alpha-fetoprotein imaging is useful for staging hepatoblastomaKalevi J A Kairemo, Harry Lindahl, Jussi Merenmies, et al.
Pageof 31